{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:37:20Z","timestamp":1787071040493,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>The purpose of the study wast to evaluate the influence of head-and-neck clinical fellowship training on multidisciplinary assessment, radiation workflow, and clinical outcomes of patients with nasopharyngeal carcinoma (NPC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This was a retrospective review of patients with NPC treated between 2010 and 2017. The study cohort was allocated into prefellowship cohort (pre-FSC) (January 2010\u2013September 2014) and postfellowship cohort (post-FSC) (October 2014\u2013December 2017). Patient demographics, tumor characteristics, multidisciplinary assessment, radiation workflow, and treatment were reviewed. Univariable, multivariable, and relapse-free survival (RFS) and overall survival (OS) were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      One hundred and forty-three patients were included, 68 in the pre-FSC and 75 in the post-FSC. For the post-FSC versus pre-FSC, there were increased multidisciplinary referrals to dental (100% vs. 79.4%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001), nutritional (94.7% vs. 70.6%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001), peg-tube insertion (84% vs. 64.7%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001), speech and swallow (94.7% vs. 13.2%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001), psychosocial (100% vs. 26.5%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001), and smoking cessation clinic (33.3% vs. 5.9%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001). For the post-FSC versus pre-FSC, there were statistically significant differences in the elements of radiation workflow; mean time required for contouring was 3.2 vs. 8.8 days (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001), radiotherapy plan implementation: 1.9 vs. 4.8 days (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001), and plan approval: 0.4 vs. 0.9 day (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.00012). On multivariable analysis, smoking was associated with poor RFS (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.04). There were no statistically significant differences in OS (94.7% vs. 87.2% at 3 years;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.126) and RFS (88.4% vs. 84.4% at 3 years;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.281) between post and pre-FSCs, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Clinical fellowship training results in increase multidisciplinary referrals to supportive services, improves radiotherapy workflow, but had no significant impact on survival outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_226_21","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T09:21:55Z","timestamp":1650273715000},"page":"733-740","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Impact of head-and-neck radiation oncology clinical fellowship on multidisciplinary assessment, radiation workflow, and survival of adult patients with nasopharyngeal carcinoma"],"prefix":"10.4103","volume":"18","author":[{"given":"Issa","family":"Mohamad","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawzi","family":"Abuhijla","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Al-Rimawi","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Al-Maayta","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdellatif","family":"Al Mousa","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiz","family":"Abu-Hijlih","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hosni","sequence":"additional","affiliation":[{"name":"The Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,4,18]]},"reference":[{"key":"R1-20250514","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ijrobp.2004.07.702","article-title":"Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experience","volume":"61","author":"Lee","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R2-20250514","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","article-title":"Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099","volume":"16","author":"Al-Sarraf","year":"1998","journal-title":"J Clin Oncol"},{"key":"R3-20250514","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","article-title":"Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma","volume":"381","author":"Zhang","year":"2019","journal-title":"N Engl J Med"},{"key":"R4-20250514","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00330-019-06500-5","article-title":"Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: Clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa","volume":"30","author":"Huang","year":"2020","journal-title":"Eur Radiol"},{"key":"R5-20250514","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3389\/fonc.2020.00930","article-title":"Quality of life, toxicity and unmet needs in nasopharyngeal cancer survivors","volume":"10","author":"McDowell","year":"2020","journal-title":"Front Oncol"},{"key":"R6-20250514","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.coms.2018.06.005","article-title":"Multidisciplinary team planning for patients with head and neck cancer","volume":"30","author":"Shellenberger","year":"2018","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"R7-20250514","first-page":"216","article-title":"Risk-adapted dental care prior to intensity-modulated radiotherapy (IMRT)","volume":"121","author":"Studer","year":"2011","journal-title":"Schweiz Monatsschr Zahnmed"},{"key":"R8-20250514","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jamaoto.2017.1855","article-title":"Multidisciplinary clinic management of head and neck cancer","volume":"143","author":"Townsend","year":"2017","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R9-20250514","doi-asserted-by":"crossref","first-page":"e15951","DOI":"10.1097\/MD.0000000000015951","article-title":"Oncologic outcomes of IMRT versus CRT for nasopharyngeal carcinoma: A meta-analysis","volume":"98","author":"Luo","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R10-20250514","doi-asserted-by":"crossref","first-page":"993","DOI":"10.7150\/jca.17858","article-title":"Long-term patterns of regional failure for nasopharyngeal carcinoma following intensity-modulated radiation therapy","volume":"8","author":"Xue","year":"2017","journal-title":"J Cancer"},{"key":"R11-20250514","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ijrobp.2019.06.2540","article-title":"International guideline on dose prioritization and acceptance criteria in radiation therapy planning for nasopharyngeal carcinoma","volume":"105","author":"Lee","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R12-20250514","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1002\/cncr.30843","article-title":"Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer","volume":"123","author":"David","year":"2017","journal-title":"Cancer"},{"key":"R13-20250514","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s13187-020-01767-5","article-title":"Radiation oncology fellowship: A value-based assessment among graduates of a mature program","volume":"36","author":"Ito","year":"2020","journal-title":"J Cancer Educ"},{"key":"R14-20250514","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1200\/JCO.2009.27.4498","article-title":"Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: Results from TROG 02.02","volume":"28","author":"Peters","year":"2010","journal-title":"J Clin Oncol"},{"key":"R15-20250514","article-title":"Moving Experience from North America to Developing Country to Approach a Desired Level of Quality Assurance in Head and Neck Radiation Therapy","author":"Mohamad","year":"2020","journal-title":"J Cancer Educ"},{"key":"R17-20250514","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1200\/GO.20.00074","article-title":"History and current state of radiation oncology services and practice in Jordan","volume":"6","author":"Khader","year":"2020","journal-title":"JCO Glob Oncol"},{"key":"R18-20250514","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.clon.2017.06.002","article-title":"Peer-assisted learning: Intensity-modulated radiotherapy transition in developing countries","volume":"29","author":"Mohamad","year":"2017","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R19-20250514","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1200\/JCO.2014.56.5218","article-title":"Institutional clinical trial accrual volume and survival of patients with head and neck cancer","volume":"33","author":"Wuthrick","year":"2015","journal-title":"J Clin Oncol"},{"key":"R20-20250514","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2007.11.016","article-title":"The relationship between waiting time for radiotherapy and clinical outcomes: A systematic review of the literature","volume":"87","author":"Chen","year":"2008","journal-title":"Radiother Oncol"},{"key":"R21-20250514","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.oraloncology.2011.06.001","article-title":"Natural course and tumor doubling time of nasopharyngeal carcinoma. A study of 15 patients","volume":"47","author":"Ho","year":"2011","journal-title":"Oral Oncol"},{"key":"R22-20250514","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(05)66698-6","article-title":"Nasopharyngeal carcinoma","volume":"365","author":"Wei","year":"2005","journal-title":"Lancet"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_226_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:40:40Z","timestamp":1787067640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_226_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_226_21","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"2021-02-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}